We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
08:45 - 09:45
Poster Area
Radiobiology
Poster Highlights
Radiobiology
FLASH Radiotherapy in pancreatic cancer: tumor growth and metastatic dissemination using the CAM Model
Paola Puccini, Italy
-2052
Timing of Janus kinase inhibition determines anti-tumor immune outcomes following radiotherapy combined with immune checkpoint inhibition
Sarah Diederich, Germany
-2192
PPAR? Agonism Enhances Systemic T-Cell–Mediated Tumor Control through Metabolic Rewiring in combined RT/anti–PD-1 therapy
Gabriele Niedermann, Germany
-2250
Decoding systemic inflammation: the TRIscore as a unifying prognostic biomarker in radiotherapy & radio-immunotherapy
Lisa Bouarroudj, France
-2927
Dietary indole-3-carbinol as a candidate therapy for radiation proctitis via inhibiting macrophage-to-myofibroblast transition
LEKUN FANG, China
-2001
Immune Effects of Neoadjuvant Chemotherapy on Muscle Invasive Bladder Cancer
Amen Shamim, United Kingdom
-2215
The interplay between the hypoxic tumour microenvironment and neutrophils in bladder cancer radiotherapy resistance
Fraser Child, United Kingdom
-4666
Optimization of FLASH split dose, fractionation, peak vs mean dose rate deliveries, by oxygen consumption measurement in vivo as a surrogate biomarker
Brian Pogue, USA
-126
Impact of NRF2, KEAP1 and HO1 on Acute Side Effects in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiation
Hatıce Kubra Isik, Turkey
-267
5-MIAA attenuates radiation proctitis in the Mongolian gerbil model
Shaomin Zou, China
-1832
Impact of Dose Fractionation and Pulse Splitting on the FLASH Effect in Ultra-High Dose-Rate Electron Irradiation
Amina JOUDAT, France
-2971
Periplaneta americana extract attenuates radiation-induced enteritis by modulating the gut microbiota
Shun Lu, China
-1884
Curcumin Mitigates Radiation Necrosis Induced by Concurrent Trastuzumab Emtansine and Radiotherapy via Aquaporin-4 Modulation
Ezgi Gurlek Tumer, Turkey
-2404
Interferon-I as a mediator of radiation-induced inflammation, with different cell fate responses in salivary and thyroid organoids.
Rob Coppes, The Netherlands
-3228
Dynamic Regulation of Macrophage Polarization by a Synthetic Lipoxin A4 Analouge in Radiation-induced Lung Injury.
Ronglan Cui, Korea Republic of
-3578
Discovery and validation of whole blood microRNAs associated with late radiation toxicity in breast cancer patients
Sara Gutiérrez-Enríquez, Spain
-4501
Evaluation of the Effect of Anti-Interleukin-6 Receptor Antibodies on Radiation-Induced Lung Injury in a Murine Model
Merve Duman, Turkey
-4749
Protective and remineralizing effects of biosilicate, chitosan-based gel and fluoride on demineralized and irradiated enamel
Harley Oliveira, Brazil
-5216
Impact of rare genetic variants in muscle repair genes on post-radiotherapy toxicities in patients with breast, lung, and prostate cancers
Miguel E Aguado-Barrera, Spain
-2830
Study on the radical kinetics driven by the beam time profile under different oxygen contents in FLASH radiotherapy
Jianhan Sun, China
-1895
A validated multiscale framework coupling an agent-based model and TOPAS-nBio for simulating spheroid growth, hypoxia, and proton response
Tiago Azevedo, Portugal
-2397
Mutational Landscape of MLH1-Deficient Colorectal Tissues and Impact of Ionizing Radiation: 3D Organoid-Based Whole Genome Sequencing Analysis
Kyung Su Kim, Korea Republic of
-1191
development of a mouse model of pericarditis associated with radiation-induced heart disease
yoshitaka suzuki, Japan
-3096
Computational evaluation of PDAC-on-chip relevance for radiobiological and chemo-radiation studies
Sofia Tartaro, Italy
-4560
Fractionation-dependent modulation of intratumoral NK and CD8? T-cell infiltration drives synergy between radiotherapy and dual PD-L1/NKG2A blockade.
Jérémy Baude, France
-687
Cardiovascular genetic risk predicts survival in thoracic but not non-thoracic cancers
Mohammad Akash, Jordan
-1445
dynamic interplay between gut microbiota and metabolism during immunotherapy-based total neoadjuvant therapy in early low rectal cancer
Wang Yang, China
-1480
Boosting radiotherapy efficacy and shaping the immune microenvironment in colorectal cancer with onion-like carbon nanophotothermal therapy.
Ruiping Guo, China
-3735
Development of AuX2R: a chemokine-directed gold nanoparticle for precision radiotherapy enhancement in prostate cancer
Niall Byrne, United Kingdom
-3850
METTL3-Mediated Epitranscriptomic Regulation Drives Pancreatic Acinar Cell Carcinoma Pathogenesis and Therapeutic Resistance
Shotaro Tatekawa, Japan
-1823
Impact of ATR or ATM kinase blockade and hypofractionated irradiation on the tumor-CD8+ T cell interface in 3D head and neck cancer models
Tina Jost, Germany
-2662
BRD9 inhibition induces selective radiosensitivity in glioblastoma through MYC pathway modulation
Nareg Degirmenci, Turkey
-4158
SBRT-Induced Immune Modulation: A Comparison of Single and Multifraction Treatments in a Preclinical NSCLC Mouse Model
Léa Bouchard, Canada
-673
Optimization of immune checkpoint inhibitor (anti-PD-1/PD-L1) dosing regimens in combination with radiotherapy
Liu SHI, France
-1043
Developing a preclinical mouse model to study image-guided stereotactic ablative radiotherapy and systemic treatment
Katrina Stevenson, United Kingdom
-1111
Opposing two-fraction regimens combining low and high doses of ionizing radiation elicit differential immune responses
Irma Telarovic, Switzerland
-2125